C066-2329 Screening compound: N'-{3-[4-(2-fluorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(piperidin-1-yl)quinolin-6-yl]butanediamide

C066-2329 Screening compound: N'-{3-[4-(2-fluorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(piperidin-1-yl)quinolin-6-yl]butanediamide
C066-2329 Screening compound: N'-{3-[4-(2-fluorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(piperidin-1-yl)quinolin-6-yl]butanediamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C066-2329
N'-{3-[4-(2-fluorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(piperidin-1-yl)quinolin-6-yl]butanediamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C066-2329

Molecular Formula

C32H41FN6O2 (C32 H41 FN6 O2)

Compound Name

N'-{3-[4-(2-fluorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(piperidin-1-yl)quinolin-6-yl]butanediamide

IUPAC name

N'-{3-[4-(2-fluorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(piperidin-1-yl)quinolin-6-yl]butanediamide

SMILES

Cc1c(cc(cc2)NC(CCC(NCCCN(CC3)CCN3c(cccc3)c3F)=O)=O)c2nc(N2CCCCC2)c1

InChI

InChI=1S/C32H41FN6O2/c1-24-22-30(39-16-5-2-6-17-39)36-28-11-10-25(23-26(24)28)35-32(41)13-12-31(40)34-14-7-15-37-18-20-38(21-19-37)29-9-4-3-8-27(29)33/h3-4,8-11,22-23H,2,5-7,12-21H2,1H3,(H,34,40)(H,35,41)

InChI Key

MZHGSOLZEXSQGC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14715296

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

560.72

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.433

Distribution Coefficient, logD

4.102

Water Solubility, LogSw

-4.17

Polar Surface Area

65.618

Acid Dissociation Constant (pKa)

11.10

Base Dissociation Constant (pKb)

7.46

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.90

C066-2329 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with C066-2329 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C066-2329?
Check Price and Availability of C066-2329, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C066-2329 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C066-2329
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C066-2329
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C066-2329 available by request